BPC-157 cost: published prices and the fees to check

By Peptide Care Index · Sources checked October 14, 2026

BPC-157 cost varies by purchase: checked advertisements list $119.95 for 60 retail capsules, $134 for a 15 mg vial order including review and shipping, and $209 per four-week 5 mg fill. These are different products and billing units, not equivalent treatments. Other required charges, applicable taxes, and the specific supply route need confirmation.

The useful comparison is what each number buys, what you pay first, and what you could still owe—not just the lowest figure on the page. A bottle price, a medical review, and a recurring care plan are different purchases.

BPC-157 cost: published prices and the fees behind them

Published BPC-157 prices can cover a retail bottle, an order after medical review, or a clinic program. Compare the exact product and required charges together. A price advertisement does not establish that the product can be prescribed or lawfully supplied to you.

The tables separate what is priced from what is still missing. All amounts are U.S. dollars. These are selected advertisements checked October 14, 2026—not completed checkouts, treatment recommendations, or a survey of the whole market. Providers are alphabetical within each group, not ranked. “Known subtotal” means documented charges added together; it is not a promise that nothing else is payable.

Capsule prices: a retail bottle is not a care package

A capsule price may cover only the bottle or include a separate medical-review charge. Match the form, strength, and count before comparing bills. Strength is the amount listed in each capsule; count is the number supplied.

Capsule offers and policies checked October 14, 2026. ProHealth’s subscription selector displayed the stated price on that date; Rx’s cost article dates its prices to September 17, 2026.

“Arginate” identifies the salt form named on ProHealth’s label. It does not establish that the retail product is the same formulation as a clinic’s capsules. We have not tested the contents of any product in this table or established its clinical equivalence to another.

Injection and clinic-program prices

An injection price may be per vial, per refill, or per advertised program. Those are not interchangeable time periods. A clinic’s required visit can also make the first bill much larger than the product price.

Injection and program sources checked October 14, 2026. Geographic descriptions are provider-published, not independent license or shipping-permission checks. Provider-labeled months describe the advertisement—not a treatment duration chosen by Peptide Care Index.

For a quote that simply says “BPC-157, $300,” the missing form and quantity matter more than whether $300 falls between two prices above. You cannot yet tell whether it buys a bottle, one vial, a consultation, or a full program.

A missing fee is unknown, not $0. A service that is not part of a retail purchase is not included, not free medical care. Before treating any subtotal as your budget, ask what is mandatory for your exact order.

Have a price but not a complete offer? Peptide Care Index's Find My Peptide Path tool brings together the access evidence, provider checks, and fee questions so you can see what still needs an answer before paying. It is free, with no account or email required.

Find My Peptide Path

Jump to your first bill, monthly and refill costs, refunds, or the quote request you can copy.

What will you actually pay to start?

Your starting bill includes every required charge for the purchase—not just the product. The amount charged today may be only the first part of that bill. Separate payment timing from the full commitment, and identify who collects each payment.

A real example: $39 now does not mean $39 total

Rx Peps Direct’s published injectable example separates the review payment from the pharmacy bill. Its $39 review is paid first; the listed medication and shipping charges follow after approval.

Source: Rx Peps Direct’s payment breakdown, checked October 14, 2026. This is the published example, not a confirmed fill or tax-inclusive personal quote.

The next order does not automatically cost only $95. The provider says the review fee applies to each order, including refills. The amount retained when a request is denied is a different question, covered in the refund section.

Which services are actually included?

A higher bill may include more services, but those services need to be named. “Medical care included” does not tell you whether a required blood test or follow-up visit will generate another invoice.

Pepti’s BPC-157 price page lists ongoing care, messaging, shipping, and supplies within its advertised fill price. It says bloodwork is not required for its BPC-157-only offer. That is the provider’s policy for the advertised service—not our judgment about which tests an individual needs. Other treatments or requirements could change the bill. Checked October 14, 2026.

For Robertson, testing and some visit charges remain unpriced in the reviewed pages. Moonshot separately lists a comprehensive blood panel at $285, but the reviewed BPC-157 offer does not establish whether that panel is required or included. Confirm the exact tests and consultation terms for the quote. Do not replace those blanks with an estimated “typical lab fee.” Ask which tests are mandatory and who bills them. Sources: Robertson’s consultation terms and Moonshot’s care description, checked October 14, 2026.

Compare two quotes with this complete-bill worksheet

Use the same purchase period for both offers, and leave missing information visible. Mark an unconfirmed amount unknown, a charge explicitly waived $0, and something outside the purchase not applicable. Record a consultation credit only when the written terms actually provide it.

Hypothetical missing-fee example: A written quote lists a $100 visit, a $200 product, $20 shipping, and mandatory tests without a price. The known subtotal is $320. The full bill is incomplete, because the test charge is unknown—not because we need to guess a higher range.

Hypothetical deposit example: A $100 deposit is explicitly credited against a $400 package. The package still costs $400, with $300 left to pay. Adding the deposit again would incorrectly turn it into $500.

For a complete purchase total, add all documented mandatory charges once, subtract only documented credits, and name any remaining unknown. For cash-flow planning, show the deposit and balance separately without changing the purchase total.

How much does BPC-157 cost per month?

There is no single monthly figure supported by these offers. A monthly plan, a four-week refill, a capsule delivery, and a one-vial order use different units. A vial’s milligrams or a bottle’s count cannot establish your monthly cost without additional, documented terms.

“Monthly” can describe five different things

Ask whether the quoted month refers to billing, supplied product, or an average over a larger purchase. Those meanings answer different budget questions. Keep the exact unit even when the seller uses “monthly” elsewhere on the page.

ProHealth’s capsule subscription uses a chosen delivery schedule; it is not automatically a monthly bill. Florida’s offer labels a program by months. Rx’s example prices an order. None of those labels gives us a reason to invent an amount to use or a treatment duration. Sources: ProHealth product, Florida offer, and Rx pricing, checked October 14, 2026.

Four-week billing can put two charges in one calendar month

Pepti’s billing terms describe renewal every 28 days, or an adjusted interval tied to the prescribed supply. That is not a promise to charge once on a fixed date each calendar month. The distinction can change how much cash you need in a particular month. Subscription and billing policy, updated August 8, 2026; checked October 14, 2026.

Hypothetical billing example: At an unchanged $209 for the advertised four-week 5 mg fill, charges on October 1 and October 29 would total $418 during October, before applicable tax or any additional charges.

Three such fills would add to $627 and represent three advertised four-week periods: 84 days, not 90. This is billing arithmetic, not a prediction of your refill schedule or a recommendation to continue treatment for that length of time. The price comes from Pepti’s BPC-157 offer, checked October 14, 2026.

Ask for the next charge date rather than assuming that “next month” means the same date next month.

Does a longer plan actually save money?

A longer plan can reduce the displayed average while increasing the amount you commit. The lower average is not the price of buying just one period. Keep the full plan price and its cancellation terms beside the monthly equivalent.

Sources checked October 14, 2026. These are two different providers’ advertised commitments, not a comparison of equivalent treatment courses. Neither division establishes what must be paid today.

Perfect B’s separate treatment-plan page describes an Optimization Panel as optional and separately priced. Optional testing is not automatically a hidden mandatory fee. Ask which tests are required for your actual quote before adding or excluding them. Checked October 14, 2026.

Pepti’s current billing policy says its three-supply prepay arrangement is no longer offered, even though legacy descriptions remain in other terms. An existing customer should use the agreement for their actual order; a new customer should not budget around an old prepay advertisement.

The same rule applies to financing. Hypothetical example: Six $100 installments for a $600 purchase still mean a $600 commitment before interest or fees. A loan payment is not the monthly medication price, and a longer repayment term is not a treatment recommendation.

What happens if you get no prescription or no fill?

No prescription does not always mean no charge. You may be paying for a professional review whether or not it leads to a prescription. Medication payments can also have a separate policy, particularly when the pharmacy—not the clinic—collects them.

Compare the money at risk, not just the refund headline

The relevant question is which payment can be retained and at what stage. A review that has begun, a pharmacy order being processed, and a shipped product are different events. Ask about denied prescriptions and failed fills separately.

Policies checked October 14, 2026. Pepti’s refund policy is dated August 8, 2026; Rx’s is dated June 2026. These are provider-published terms, not a legal opinion about an individual dispute or a guarantee that a request will be approved.

For Pepti, the difference between not being charged and being refunded later matters even when the declined medication’s eventual net charge is meant to be zero. Budget for the policy’s stated initial payment unless the provider confirms a different checkout arrangement in writing.

Pepti’s product information also says a charge is refunded if the product cannot be dispensed. That does not establish the timing for every failed-fill situation. Do not assume the denial-refund timeline also resolves a later dispensing problem. BPC-157 product information, checked October 14, 2026.

Cancelling future refills is not the same as refunding an order

Stopping future charges does not necessarily cancel work already underway or refund a supply already sent. Check the next billing date and the current order’s status. Get written confirmation of what your cancellation stops.

Pepti provides account and email cancellation routes in its official cancellation policy. Its refund policy distinguishes cancellation before pharmacy processing from medication already shipped; shipped orders are generally nonrefundable under its terms, with specified exceptions such as damage or billing errors. Do not read a heading about unshipped orders as a guarantee that every unshipped order can still be refunded. Policies checked October 14, 2026.

Rx Peps Direct’s current pricing page says automatic refills are optional and can be turned off in the dashboard. Its cost article uses broader wording about having no subscription or nothing to cancel. The practical answer is to check whether you opted into refills—not to assume that a lack of membership means no recurring orders. Sources checked October 14, 2026.

Already paid? Use the official policy and contact route for the organization that collected the payment. For an Rx medication payment, that may be the dispensing pharmacy rather than the review service. Keep the receipt, charge date, and cancellation confirmation together; do not send them to Peptide Care Index.

Are capsules cheaper than injections?

A capsule order can have a lower listed bill than an injection order without being a cheaper equivalent treatment. Compare the form, quantity, services, and billing period first. The prices above do not establish a clinically interchangeable choice.

Compare the package—not an assumed result

In the Rx examples, the $129 order for 30 capsules is $5 below the $134 order for one 15 mg vial, including the stated review and shipping charges. That is an order-price difference, not evidence that the capsule product provides the same benefit for less money. Sources: capsule-order example and vial-order breakdown, checked October 14, 2026.

The two Robertson listings show why “oral is always cheaper” is also too simple: its listed capsule product costs more than its listed injection product, before the shared consultation requirement. The products have different quantities and routes, so this does not establish that injections are better value. Robertson product listings, checked October 14, 2026.

Even matching capsule counts or labeled milligrams does not prove matching ingredients, measured contents, absorption, or clinical effects. Swallowed capsules are also not interchangeable evidence for a product held under the tongue. Sublingual means placed under the tongue; it is a different route from swallowing.

A 5 mL vial does not tell you how much BPC-157 it contains

Milliliters, written mL, measure liquid volume. Milligrams, written mg, measure the listed amount of substance. You need both the concentration and volume to identify the advertised vial quantity.

In the source examples, 5 mL × 2 mg/mL = 10 mg for Robertson, while 5 mL × 3 mg/mL = 15 mg for Rx. The bottles contain the same stated liquid volume but different labeled amounts. This is package arithmetic—not a dose conversion or instruction for use. Sources: Robertson and Rx, checked October 14, 2026.

A cost-per-milligram figure can describe an item’s labeled quantity price. It cannot tell you how long the product will last, whether different forms work alike, or which amount is appropriate. It also hides consultation and other charges unless those are shown separately.

Is a prefilled pen more expensive?

Pepti still lists $319 for a 9 mg pen cartridge, but its product selector marked that format sold out when checked October 14, 2026. Its standard 5 mg vial fill is listed at $209. The pen number is a posted price for a format marked unavailable—not a confirmed purchasing option. Product selector, formulation, and price FAQ.

The quantities also differ, so the gap is not just a device charge on an identical order. The FAQ advertises the first reusable injector as included; that does not override the sold-out notice. A different container does not itself establish better results, and this comparison is not a reason to choose a particular strength or route.

What about a BPC-157 and TB-500 blend?

A blend is a separate purchase from BPC-157 alone. Without an itemized price and ingredient quantities, you cannot calculate what the BPC-157 part costs. Another ingredient does not by itself establish added benefit.

Source checked October 14, 2026. The advertised period is not a course recommendation. “TB-500” in a commercial name does not identify the exact substance; ask whether the seller means a fragment or full-length thymosin beta-4. Do not treat them as the same ingredient.

We have not priced every sublingual, nasal, or topical product. A missing form in this comparison means it was not priced here—not that it is unavailable or that another route’s price can stand in for it.

Why does a clinic charge more than a research vial?

A research supplier prices a laboratory product; a clinic may price evaluation and a care arrangement. Those are different categories. A lower research-item price is not a patient-care alternative just because the peptide name looks the same.

For example, American Peptides’ product listing displays $60 for a 5 mg BPC-157 research item. Its intended-use terms restrict it to laboratory research, not human or veterinary use. The $60 is an item price, not a delivered care bill; shipping, tax, and any additional purchasing requirements must be kept separate. The page also displays an add-on marked required, so the headline alone does not establish the checkout total. Product and intended-use restrictions checked October 14, 2026.

That example explains a category difference. It is not a supplier recommendation, an available prescription option, or a budget for treating yourself.

Which part of a clinic’s price is paying for care?

Ask the clinic to name the services included in its bill. Review time, follow-up, required tests, supplies, and coordination may explain part of a price difference—but only when they are actually included. An unexplained premium remains unexplained.

A practical comparison is: “Who answers questions after the first visit, what follow-up is included, and what would cost extra?” You can evaluate the clarity of that answer without assuming that the higher-priced product is more effective.

A high price does not prove quality, and a low price alone does not prove a fake product. There is no price threshold in this comparison that authenticates a vial or bottle.

What does a certificate of analysis tell you?

A certificate of analysis, or COA, reports specified tests on a stated sample. Its meaning depends on the sample, lot, test methods, and results—not just a prominent purity percentage. We did not independently test or authenticate any product’s COA for this comparison.

Identity or purity testing alone does not establish clinical benefit, patient suitability, or a lawful supply route. It also does not establish sterility unless the document actually reports an applicable sterility test; even that test would not answer the other questions. FDA’s BPC-157 briefing distinguishes route-specific quality requirements, including sterility concerns for injected preparations. FDA staff evaluation, quality discussion, dated May 11, 2026; checked October 14, 2026.

Paying more for a product described as “medical grade” does not remove the need to ask what was tested and which exact product could be supplied.

Will insurance, Medicare, HSA, or FSA pay?

Use the cash price in your budget unless your plan confirms coverage for the exact charge. A medical visit, a lab test, and a product can have different coverage answers. Acceptance of an insurance card or payment card does not settle all three.

Check the product, visit, and labs separately

Ask for the billing entity and the exact service or product description before seeking a benefit answer. Where relevant, ask the provider for the billing code. A general statement that a practice accepts insurance is not confirmation of coverage for its BPC-157 offer.

The Pepti and Moonshot offer pages describe self-pay pricing rather than a confirmed insured price for the product. We have not checked every private plan. These sources do not support a universal claim that insurance covers nothing associated with an appointment, or an assumed product copay. Pages checked October 14, 2026.

For Medicare Part D, the rule is more specific than “all compounded drugs are excluded.” CMS’s manual says bulk powders—active pharmaceutical ingredients used for compounding—are not Part D drugs and are not covered by Part D; coverage for a compounded prescription is limited to qualifying Part D components. A BPC-157 bulk-ingredient charge does not become a covered Part D ingredient simply because a pharmacy compounds it. Separately billed medical services require their own benefit determination. CMS Part D Benefits Manual, chapter 6, section 10.4, PDF pages 5–6, revision January 15, 2016; current 42 CFR 423.120(d) also reviewed. Checked October 14, 2026.

HSA/FSA acceptance is not a tax-eligibility decision

An HSA or FSA can pay qualified medical expenses under the applicable rules; a card transaction alone does not show that the expense qualifies. Keep an itemized receipt and do not assume a tax benefit just because the seller accepts the card. IRS Publication 969, 2025 edition, checked October 14, 2026.

For an FSA, ask the plan administrator about the exact expense and required documentation. For uncertain HSA tax treatment, get advice from a qualified tax professional. This comparison makes no BPC-157-specific eligibility finding and does not subtract presumed tax savings from advertised prices.

Does a listed price mean you can receive BPC-157?

A price page establishes an advertisement, not permission to supply a particular product to you. A prescription, a pharmacy license, and a compounding claim each answer only part of the access question. Confirm the exact formulation and dispensing pharmacy before paying a nonrefundable fee.

What the official records establish

FDA approval of a finished medicine is different from a compounding policy or a committee discussion. The specific BPC-157 forms and the date of the record matter. Do not treat a change in a nomination’s status as approval of a product.

FDA’s May 11, 2026 staff evaluation, prepared for an advisory meeting, states that neither BPC-157 free base nor BPC-157 acetate is a component of an FDA-approved drug and that neither has an applicable U.S. Pharmacopeia or National Formulary monograph. A monograph is an official quality standard. The quoted finding concerns those two forms; it is not a separate evaluation of the retail arginate product above. FDA briefing, page 9, checked October 14, 2026.

The current FDA safety page places BPC-157 among substances whose nominations were withdrawn after earlier Category 2 placement. The 503A bulk-substance list, displayed current through October 9, 2026 when checked, does not list BPC-157. Those are specific findings—not a complete determination about every possible transaction. Both records were checked October 14, 2026.

The July 2026 advisory meeting was not itself product approval or a final listing decision. FDA’s 503A framework contains ingredient-specific conditions and an interim policy; a provider’s statement that it uses a licensed pharmacy does not resolve them. Records checked October 14, 2026.

“Off-label” has a different meaning: using an FDA-approved drug for a use outside its approved labeling. Calling a compounded BPC-157 offer off-label does not establish that it is an approved finished medicine. FDA’s explanation of off-label use, checked October 14, 2026.

For the advertisements in this comparison, we have not established the lawful patient-specific supply route. The practical question is: “Which exact ingredient and formulation would the named pharmacy supply, and what current source supports doing so?”

Check the requirement, not a blanket “verified” badge

The Peptide Care Access Check attaches a finding to a specific requirement. A price can be documented while another part of the same offer remains unresolved. These labels do not rate a provider’s clinical quality or say a product is safe.

Findings checked October 14, 2026. The method also uses “Not applicable” where a criterion does not supply an access basis. No label in this table is an endorsement.

A price may be clear while the supply question is not. Find My Peptide Path brings the dated access summaries and provider questions together, so you can check both before committing to a visit or order.

Find My Peptide Path

Is paying more worth it?

Paying more can buy documented services, but the price does not establish a better treatment result. Compare service, payment risk, and evidence separately. The offers here do not support a reliable “cost per recovery” or a promise that spending more will avoid surgery or another expense.

What a higher price can usefully buy

A clearly priced consultation, accessible follow-up, and an identified pharmacy give you more information about the service than an unexplained premium does. Ask what is included and who handles problems. Do not assume those features are present merely because the bill is higher.

For a like-for-like financial comparison, the written quotes must cover the same stated product, quantity, services, and period. Even then, price comparison alone does not prove clinical equivalence or make the lower-priced option appropriate.

Our verdict: These sources support comparing advertised bills and spotting incomplete terms. They do not establish a cheapest clinically equivalent BPC-157 treatment or a “best value” provider. When the product, required fees, or supply basis is still unclear, getting an answer before paying is more useful than chasing a smaller headline price.

What the human evidence cannot turn into a savings claim

A small positive human report can justify further study without telling a new customer what benefit their purchase will deliver. One often-cited knee-pain report used a different route from the capsule and under-the-skin offers above. It did not measure their financial value.

Source: Original report, methods and results including printed page 10, published July/August 2021; checked October 14, 2026. Subcutaneous means under the skin, not into a joint.

That finding is not proof of no benefit, and it is not proof that a current clinic package will reproduce the result. It gives no defensible number for “dollars per healed injury.”

A useful clinical discussion asks what evidence applies to the exact form and intended use, which established alternatives deserve comparison, what outcome would be assessed, and what would prompt stopping rather than continuing payments. Those are questions for making a decision—not a BPC-157 protocol.

Reduce financial risk without changing treatment

Clarifying fees, avoiding unwanted renewal, and declining an unclear long commitment can reduce payment risk. Changing the amount used or stretching a vial to fit a budget is not a cost-saving method this page recommends.

Ask whether a discount applies only to the product or also to required fees, and whether it ends at renewal. An old quote, forum post, or expired promotion does not establish today’s bill. Keep the offer date, quantity, and conditions with every price you compare.

How we checked these prices

We compared the cited product, clinic, price, and policy pages, then checked the arithmetic without assuming a treatment schedule. Seller sources establish advertisements; official records establish the narrower regulatory or payment facts stated here. A source check is not a completed purchase or confirmation of supply.

Peptide Care Index is the independent decision and access index for peptide care—helping you understand the route, the cost, the evidence, and the next step before you pay.

What we actually checked

Sources were checked October 14, 2026. We read selected product specifications, consultation requirements, shipping, billing, cancellation, and refund terms; reviewed the cited FDA/eCFR, CMS, and IRS records; and inspected the original knee-pain report. We kept source publication dates separate from check dates and identified material differences between a price page and its policy.

The examples are a selected, alphabetical comparison—not the whole market or an overall ranking. Prices and service descriptions remain provider-published. We did not complete checkouts, buy or test products, contact providers, check individual licenses, inspect pharmacies, or verify patient-specific availability. No clinician, pharmacist, or regulatory specialist reviewed this article. AI assisted the research and drafting; editorial source review is not specialist review.

The research methodology explains the finding labels and comparison rules. Our editorial standards explain the use of AI assistance and corrections. Current provider source links are unpaid; see how this publication is funded. The byline links to the accountable publisher profile.

A changed price should change the relevant row, arithmetic, and explanation—not just the date at the top. To report a discrepancy, use Contact and corrections and identify the public source. Please do not send medical records, prescription details, or private payment information.

Get a complete quote before you pay

Ask each organization for the same details so the replies can be compared. Keep the product, full commitment, next bill, and no-fill refund rules together. You can use this request with a provider you already know; you do not need to choose a different one.

Copy this quote request

Before I pay, please confirm the exact BPC-157 service and product being considered: all active ingredients, salt or form, route, strength, and total quantity. Please identify the dispensing pharmacy, whether it can serve my state, and the current source supporting supply of this exact product.

Please itemize the consultation or review, product, mandatory tests, membership, shipping, supplies, required follow-up, and applicable taxes or other charges. Which items are included, which are optional, and which amounts are only starting prices? Who collects each payment?

What will I pay now, later in the same commitment, and for the next order? Please show any deposit credit without counting it twice. Is the billing unit an order, a delivery, 28 days, a calendar month, or another period?

Does anything renew automatically? What is the full commitment, and how do I stop future charges? Please give the cancellation deadline and explain whether it also stops an order already being processed.

If no prescription is issued, what is refunded and what is retained? If a prescription is issued but the pharmacy cannot fill it, who handles the refund for the product and shipping? At what point does each payment become nonrefundable?

Please provide the applicable clinic and pharmacy policies in writing, rather than only a monthly equivalent or a general refund promise.

You now know what a usable price quote should contain. For the access evidence and the rest of the provider checks, use Find My Peptide Path. It brings those checks together with questions you can copy or print—free, without an account or email.

Find My Peptide Path

Sources and check dates

The links beside each price lead to the exact offer or policy used. Provider pages establish advertised terms, not independently confirmed fulfillment or treatment results. The check date is October 14, 2026; older document or price dates remain identified where they matter.